{"id":1784,"date":"2015-11-06T09:53:58","date_gmt":"2015-11-06T09:53:58","guid":{"rendered":"https:\/\/palladiumcapital.com\/?p=1784"},"modified":"2015-12-24T13:34:37","modified_gmt":"2015-12-24T13:34:37","slug":"palladium-capital-advisors-completes-500000-bridge-financing-for-accelerated-pharma-inc","status":"publish","type":"post","link":"https:\/\/www.palladiumcapital.com\/palladium-capital-advisors-completes-500000-bridge-financing-for-accelerated-pharma-inc\/","title":{"rendered":"Palladium Capital Advisors Completes $500,000 Bridge Financing for Accelerated Pharma"},"content":{"rendered":"<p><a href=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/11\/Accelerated-Pharma-Nov-2015-Tombstone.png\"><img decoding=\"async\" loading=\"lazy\" class=\"alignright wp-image-1792 size-medium\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2015\/11\/Accelerated-Pharma-Nov-2015-Tombstone-263x300.png\" alt=\"Accelerated Pharma Nov 2015 Tombstone\" width=\"263\" height=\"300\" srcset=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2015\/11\/Accelerated-Pharma-Nov-2015-Tombstone-263x300.png 263w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2015\/11\/Accelerated-Pharma-Nov-2015-Tombstone.png 570w\" sizes=\"(max-width: 263px) 100vw, 263px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>New York, NY\u2013(November\u00a06, 2015) \u2013 Palladium Capital Advisors, LLC today announced that it acted as exclusive placement agent for Accelerated Pharma, Inc in its $500,000 private offering of secured convertible promissory notes and warrants.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Accelerated Pharma\u00a0<\/strong>is a late-stage pharmaceutical company with a potential blockbuster cancer drug, Picoplatin, which is progressing towards Phase II trials. Picoplatin is a next generation platinum-based chemotherapy that may offer significant improvement over current standards of care.<\/p>\n<p>&nbsp;<\/p>\n<p>Accelerated Pharma\u2019s mission is to enhance cancer drug development by repositioning late-stage clinical projects utilizing a proprietary genomic platform that targets patients who have the greatest chances of responding to our pipeline of therapies. The company\u2019s management has a proven track record for guiding clinical development and obtaining regulatory approval. The team has secured approval for eight different drugs with wide adoption from regulatory authorities. The company is pursuing commercial approval for Picoplatin in the US and other key markets based on \u00a0\u00a0safety and efficacy data demonstrated to date. Accelerated Pharma plans to finalize its choice of lead indication following anticipated FDA guidance.<\/p>\n<p>&nbsp;<\/p>\n<p>Learn more about Accelerated Pharma at\u00a0http:\/\/www.apipharmaceuticals.com\/<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; New York, NY\u2013(November\u00a06, 2015) \u2013 Palladium Capital Advisors, LLC today announced that it acted as exclusive placement agent for Accelerated Pharma, Inc in its $500,000 private offering of secured convertible promissory notes and warrants. &nbsp; Accelerated Pharma\u00a0is a late-stage pharmaceutical company with a potential blockbuster cancer drug, Picoplatin, which is progressing towards Phase II [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"_links":{"self":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/1784"}],"collection":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/comments?post=1784"}],"version-history":[{"count":0,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/1784\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media?parent=1784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/categories?post=1784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/tags?post=1784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}